Komori
Earth (4985) · FactContinued changes in the composition of major customers

Concentration of Sales Among Major Customers

First written in FY2022. . Latest entry: FY2025.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022 – FY20252023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Disclosure of Major Customers and Customer Sales MixA theme 16 companies write about · 12 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 2 of 12 companies on the "Worse" side.

10 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 16 companies compared. The sentences above are computed from all 16.
Full recordFilings, disclosures and news, newest first
  1. FY2025Continued changes in the composition of major customersAnnual report

    「株式会社PALTAC 45,667 25.5 ㈱あらた 40,307 22.5 ㈱大木 19,626 11.0」

    2025年度もPALTAC、あらた、大木の3社が総販売実績の10%超を占めた。比率はPALTAC25.5%、あらた22.5%、大木11.0%となった。
  2. FY2024Change in the composition of major customersAnnual report

    「㈱PALTAC 45,178 26.7 ㈱あらた 40,191 23.7 ㈱大木 17,639 10.4 アルフレッサ ヘルスケア㈱ - -」

    2024年度はPALTAC、あらた、大木の3社が総販売実績の10%超となり、前年度に10%超だったアルフレッサ ヘルスケアは10%未満となった。
  3. FY2023主要販売先が4社に拡大Annual report

    「㈱あらた 39,890 25.2 ㈱PALTAC 37,831 23.9 アルフレッサ ヘルスケア㈱ 20,608 13.0 ㈱大木 16,471 10.4」

    2023年度は、総販売実績に占める割合が10%を超える主要販売先として、あらた、PALTAC、アルフレッサ ヘルスケア及び大木の4社が開示された。
  4. FY2022First statedAnnual report

    「㈱PALTAC 39,209 25.7 ㈱あらた 37,414 24.6 アルフレッサ ヘルスケア㈱ 19,422 12.7」

    2022年度の総販売実績に占める割合として、PALTAC25.7%、あらた24.6%、アルフレッサ ヘルスケア12.7%を開示しており、主要販売先への売上集中を示す新たなデータ点である。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Earth's next results are scheduled for 2026-11-09. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.